Search Within

Franz Edward Boas

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (12)
Groups
  1. Center for Pancreatic Cancer Research (26)
  2. Department of Medicine (26)
  3. Gastrointestinal Oncology Service (26)
  4. Radiology, Department of (26)
  5. Solid Tumor Oncology Division (26)
  6. Interventional Radiology Service (25)

More Groups

People
  1. Hooman Yarmohammadi (24)
  2. Stephen Solomon (21)
  3. Etay Ziv (19)
  4. Constantinos Sofocleous (14)
  5. Joseph Erinjeri (13)
  6. Nancy Kemeny (10)

More People

Years
  1. 2022 (1)
  2. 2021 (10)
  3. 2020 (5)
  4. 2019 (4)
  5. 2018 (2)
  6. 2017 (4)
Publications
  1. Journal of Vascular and Interventional Radiology (12)
  2. Clinical Colorectal Cancer (2)
  3. HPB (2)
  4. Journal of Clinical Oncology (2)
  5. Radiology (2)
  6. Abdominal Radiology (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (14)
  2. Elsevier Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. Radiological Society of North America, Inc. (2)
  5. American Roentgen Ray Society (1)
  6. Impact Journals (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DAXX mutation status of embolization-treated neuroendocrine tumors predicts shorter time to hepatic progression
    Journal Article

    Ziv, E.; Rice, S. L.; Filtes, J.; Yarmohammadi, H.; Boas, F. E.; Erinjeri, J. P.; Petre, E. N.; Brody, L. A.; Brown, K. T.; Covey, A. M.; more...
    Journal of Vascular and Interventional Radiology (2018)

    Fulltext@MSK | Save
  • DAXX mutation is associated with shorter hepatic progression free survival after hepatic artery embolization of neuroendocrine liver metastases
    Meeting Abstract

    Ziv, E.; Boas, F.; Yarmohammadi, H.; Filtes, J.; Brown, K.; Covey, A.; Solomon, S.; Reidy, D.; Erinjeri, J.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Reply to: “Adjuvant medications that improve survival after locoregional therapy”
    Journal Article

    Boas, F. E.; Ziv, E.; Yarmohammadi, H.; Brown, K. T.; Erinjeri, J. P.; Sofocleous, C. T.; Harding, J. J.; Solomon, S. B.
    Journal of Vascular and Interventional Radiology (2017)

    Fulltext@MSK | Save
  • Adjuvant medications that improve survival after locoregional therapy
    Journal Article

    Boas, F. E.; Ziv, E.; Yarmohammadi, H.; Brown, K. T.; Erinjeri, J. P.; Sofocleous, C. T.; Harding, J. J.; Solomon, S. B.
    Journal of Vascular and Interventional Radiology (2017)

    Fulltext@MSK | Save
  • PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases
    Journal Article

    Ziv, E.; Bergen, M.; Yarmohammadi, H.; Boas, F. E.; Petre, E. N.; Sofocleous, C. T.; Yaeger, R.; Solit, D. B.; Solomon, S. B.; Erinjeri, J. P.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Gene signature associated with upregulation of the Wnt/β-catenin signaling pathway predicts tumor response to transarterial embolization
    Journal Article

    Ziv, E.; Yarmohammadi, H.; Boas, F. E.; Petre, E. N.; Brown, K. T.; Solomon, S. B.; Solit, D.; Reidy, D.; Erinjeri, J. P.
    Journal of Vascular and Interventional Radiology (2017)

    Fulltext@MSK | Save